S. Cuéllar

发表

National trends in prescription drug expenditures and projections for 2019.

J. Hoffman, G. Schumock, K. Suda, 2019, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

HIV testing history and access to treatment among migrants living with HIV in Europe

A. Copas, B. Ledergerber, S. Corrao, 2018, Journal of the International AIDS Society.

BCR-ABL1 tyrosine kinase inhibitors for the treatment of chronic myeloid leukemia

S. Cuéllar, M. Vozniak, Jill Rhodes, 2017, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

Virological outcome among HIV infected patients transferred from pediatric care to adult units in Madrid, Spain (1997–2017)

P. Soler-Palacín, Á. Holguín, J. Losa, 2020, Scientific Reports.

Understanding and managing the possible adverse effects associated with bevacizumab.

Stacy S Shord, S. Cuéllar, Linda R Bressler, 2009, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

Chemotherapy-induced anemia at an urban academic medical center: iron studies and supplementation.

S. Cuéllar, S. Shord, 2008, Journal of the American Pharmacists Association : JAPhA.

Parenteral iron with erythropoiesis-stimulating agents for chemotherapy-induced anemia

J. M. Hamilton, S. Cuéllar, S. Shord, 2008, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

Adherence to Oral Anticancer Medications: Evolving Interprofessional Roles and Pharmacist Workforce Considerations

S. Crawford, N. Venepalli, A. Boyd, 2018, Pharmacy.

National trends in prescription drug expenditures and projections for 2020.

J. Hoffman, G. Schumock, K. Suda, 2020, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

Design of Customized Mobile Application for Patient Adherence to Oral Anticancer Medications Utilizing User-Centered Design

S. Crawford, N. Venepalli, A. Boyd, 2017 .

Updates in the Use of the mTOR Inhibitor Everolimus in Advanced Breast Cancer

Jennifer L. Anderson, S. Cuéllar, 2016 .

The Current Landscape for METex14 Skipping Mutations in Non–Small Cell Lung Cancer

S. Cuéllar, Alisha Desai, 2022, Journal of the advanced practitioner in oncology.

National trends in prescription drug expenditures and projections for 2022

J. Hoffman, G. Schumock, K. Suda, 2022, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

Role of HIV in the desire of procreation and motherhood in women living with HIV in Spain: a qualitative approach

S. Cuéllar, J. del Romero, J. Blanco, 2018, BMC Women's Health.

Discovering HIV related information by means of association rules and machine learning

Miguel Ángel Martínez, Juan Martínez-Romo, Lourdes Araujo, 2022, Scientific Reports.

Dynamics of creatinine estimated glomerular filtration rate using one or more antiretrovirals that inhibit creatinine tubular secretion.

E. Negredo, E. Martinez, J. De La Torre, 2021, The Journal of antimicrobial chemotherapy.

National trends in prescription drug expenditures and projections for 2021

G. Schumock, K. Suda, M. Wiest, 2021, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

Barriers to health care services for migrants living with HIV in Spain

J. Miro, B. Ledergerber, E. Fernández, 2018, European journal of public health.

Novel Targets in the Treatment of Advanced Melanoma: New First-Line Treatment Options

S. Cuéllar, K. Culos, 2013, The Annals of pharmacotherapy.

Transfusions increase with nationally driven reimbursement changes of erythropoiesis stimulating agents for chemotherapy-induced anemia

S. Cuéllar, S. Shord, J. M. Yu, 2011, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

Impact of an enhanced screening program on the detection of non-AIDS neoplasias in patients with human immunodeficiency virus infection

D. Podzamczer, J. Mallolas, J. Losa, 2021, Trials.

Prevalence of M184V and K65R in proviral DNA from PBMCs in HIV-infected youths with lamivudine/emtricitabine exposure

P. Soler-Palacín, Á. Holguín, J. Losa, 2021, The Journal of antimicrobial chemotherapy.

Complete Response of CNS-involved Olfactory Neuroendocrine Tumor Using Multimodal Therapy

S. Setty, S. Cuéllar, M. Yao, 2008, Oncology Research and Treatment.

High delayed mortality after the first episode of Clostridium difficile infection.

A. Muriel, A. Royuela, M. Salavert, 2019, Anaerobe.

Pharmacist perspectives and considerations for implementation of therapeutic oncology biosimilars in practice.

S. Cuéllar, A. McBride, P. Medina, 2019, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

Integrating trastuzumab biosimilars and HER2-directed therapies into HER2-positive breast cancer management.

S. Cuéllar, 2020, The American journal of managed care.

The life, death, and attempted rebirth of bevacizumab in breast cancer

S. Cuéllar, Amanda N. Seddon, C. Haaf, 2014, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

Targeting the mammalian target of rapamycin pathway with everolimus: Implications for the management of metastatic breast cancer

J. Johnson, S. Cuéllar, V. Ng, 2015, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

Outcomes by sex following treatment initiation with darunavir/cobicistat in a large Spanish cohort of the CODAR study (GeSIDA 9316).

J. M. García de Lomas, J. De La Torre, E. Ribera, 2019, The Journal of antimicrobial chemotherapy.

[Boosted protease inhibitor monotherapy in HIV-infected patients: results of a study in a real life setting].

M. Salavert, S. Cuéllar, M. Blanes, 2015, Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia.

Examining ethnic differences for bevacizumab-induced hypertension and proteinuria

J. Villano, S. Cuéllar, S. Shord, 2007 .

Patient-centered design in developing a mobile application for oral anticancer medications.

S. Crawford, N. Venepalli, A. Boyd, 2019, Journal of the American Pharmacists Association : JAPhA.

Smoking Cessation and Opportunities for Oncology Pharmacists

Bcop, S. Cuéllar, Pharmd, 2015 .

Severe Psychiatric Symptoms in a Patient With EGFR Exon-20 Insertion Mutation Receiving Mobocertinib: A Case Report

S. Cuéllar, J. Kamel, L. Feldman, 2021, JTO clinical and research reports.

Pharmacological management of anticancer agent extravasation: A single institutional guideline

S. Cuéllar, Jennifer L. Anderson, P. Fleming, 2018, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

Prediction of recurrent clostridium difficile infection at the bedside: the GEIH-CDI score.

M. Salavert, S. Cuéllar, C. Henriquez-Camacho, 2017, International journal of antimicrobial agents.

Expanding HIV clinical monitoring: the role of CD4, CD8, and CD4/CD8 ratio in predicting non-AIDS events

Miguel Ángel Martínez, B. Rodés, E. Poveda, 2023, EBioMedicine.